Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
Tamas A. Gonda, MD, 2014 recipient of the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research, is examining how...
This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...
With the start of the AACR Annual Meeting 2015 only four days away, the organization is ramping up its...
In addition to providing a forum for attendees to learn, network, and share information and ideas, the Annual Meeting...